Mifepristone Drug-Drug Interaction Study With CYP3A Inhibitor
NCT03259542
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
33
Enrollment
INDUSTRY
Sponsor class
Conditions
Drug Interaction Potentiation
Healthy
Interventions
DRUG:
Mifepristone 300 MG
DRUG:
Itraconazole 100 MG
Sponsor
Corcept Therapeutics